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1. Introduction 
The importance of the microtubular apparatus for 
the process of exocytosis in secretory organs, including 
the pancreatic beta-cell, has been inferred from recent 
studies showing that agents which interfere with 
microtubular function also influence secretory 
responses. Such agents may either disrupt micro- 
tubules (colchicine, Vinca alcaloids) (for review see 
[l]), or ‘stabilize’ them, thus causing reversible 
functional impairments (DzO) [2-51. 
To investigate possible interrelationships between 
the adenylate cyclase-cyclic AMP system, micro- 
tubular function, and insulin secretion, the effects of 
deuterated water on cyclic AMP metabolism has been 
studied in isolated rat islets of Langerhans. Using a 
prelabeling method for assessing changes in cyclic 
AMP metabolism, it is shown here that DzO, in 
addition to its well established inhibitory effect on 
insulin release, suppresses the efflux of cyclic 
nucleotide from the islets. On the other hand, the 
glucose-induced intra-islet accumulation of cyclic 
AMP is greatly enhanced. This latter finding is in 
contradistinction to the moderate effects of DzO 
when tested together with a phosphodiesterase 
inhibitor (3-isobutyl-1-methylxanthine, IBMX) or 
the adenylate cyclase activator cholera toxin. The 
results suggest hat different compartments of cyclic 
AMP exist within the beta-cell, a possibly microtubule 
associated one being stimulated specifically by 
glucose. 
2. Materials and methods 
Pancreatic islets were isolated from fed male 
Sprague-Dawley rats by a modified collagenase 
technique [6]. Krebs-Henseleit bicarbonate buffer 
(KHB), containing 2 mg/ml bovine albumin, 10 mM 
Hepes and - when not otherwise indicated - 3.3 mM 
glucose was used throughout. All solutions containing 
the agents to be tested were adjusted to pH 7.4 (pH 
meter). Islets were pulse-labeled with [2-3H]adenine 
(100 @i/ml) for 60 min, washed and incubated in 
groups of 1.5 as described previously [7]. Incubations 
were terminated by boiling, and cyclic AMP purified 
basically according to the technique of Krishna [8]. 
Insulin was measured by radioimmunoassay [9, IO] . 
For measurement of phosphodiesterase activity, 
250 islets were collected (without prior preincubation) 
in a small homogenizer containing 0.5 ml of KHB and 
homogenized manually (10 strokes). 20 ~1 aliquots 
were added to incubation tubes containing 25 ~1 
100 mM Tris-HCI, pH 8.0 and 12 mM MgClz, 10 4 
of [3H]cyclic AMP (200 000 cpm) and 40 ~1 of 
cyclic AMP in various concentrations. The time 
between the onset of homogenization and the start 
of the incubations was kept constant to 1 min. 
Incubations were carried out for 20 min at 37°C and 
terminated by boiling. Control experiments showed 
the reaction rate to be linear for at least 30 min 
incubation. After cooling, 20 ~1 of the nucleotidase- 
containing C?otalus afrox venom (1 mg/ml) was 
added and incubations continued for 20 min. 100 ~1 
North-Holland Publishing Company - Amsterdam 165 
Volume 68. number 2 FEBS LETTERS October 1976 
of lo-’ M adenosine was then added, followed by 
1 ml of a resin slurry (50% HzO, v/v) of Biorad AC 
l-X2-400 mesh. After centrifugation, aliquots of the 
supernatant were counted for [3H]adenosine. From 
parallel incubations, where labeled adenosine was 
measured before and after resin addition, it was 
possible to correct for the substantial (64.1%) but 
constant (range of triplicates 0.6%) binding of 
adenosine to the resin. 
Crude collagenase was purchased from Worthington 
Biochemical Corporation, Freehold, N.J., USA; bovine 
albumin (Fraction V) from Armour Co, Eastbourne, 
UK; DzO (99.8%) from Norsk Hydro, Oslo, Norway; 
3-isobutyl-1-methylxanthine (IBMX) was obtained 
from Aldrich Co, Milwaukee, Wis., USA; cyclic AMP, 
N-2-hydroxyethylpiperazine-fV-2-ethanesulfonic a id 
(HEPES) and Crotdus atrox venom from Sigma 
125 
15min 1 
Chemicals, Saint Louis, MO., USA; [2-3H]adenine 
(specific activity 31.7 Ci/mmol) and cyclic [3H]AMP 
(specific activity 37.7 Ci/mmol) from New England 
Nuclear, Dreiechenhain, West Germany. Rat insulin, 
used as a standard in the immunoassay, was a kind 
gift of Dr J. Schlichtkrull, Novo Research Institute, 
Copenhagen, Denmark. 
3. Results 
The stimulatory effects of glucose, tested together 
with a submaximal concentration (0.1 mM) of the 
phosphodiesterase inhibitor (IBMX), both on cyclic 
AMP accumulation and insulin release are evident 
from fig. 1. In agreement with previous results [2] , the 
glucose-induced intracellular rise in cyclic AMP was 
more marked after 15 than 60 min incubation, while 
the cyclic nucleotide and insulin continued to accu- 
mulate in the incubation medium throughout the 
incubation period. The addition of DzO at a final 
tissue medium 
3.3 27.7 
60lllin 15mm 
A 
3.3 27.7 
GLUCOSE mM 
Fig.1. Effects of 50% D,O (hatched columns) in the presence of 3.3 or 27.7 mM glucose on insulin release (IRI) (left panels) and 
cyclic [ 3H]AMP accumulation i  islets and incubation media (middle and right panels, respectively) after 15 and 60 min of 
incubation. 0.1 mM IBMX was included in all incubations. Mean f S.E.M. of 4 complete experiments. Effects of D,O together 
with 27.7 mM glucose were significant on IRI (p < 0.02 and < O.OOl), on intra-islet (p < 0.005 and < 0.025) and medium 
cyclic [‘HI AMP @ < 0.025 and < 0.05) for 15 and 60 min of incubations, respectively. 
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concentration of 50% caused nearly complete inhibi- 
tion of the glucose-induced insulin release as well as 
of the efflux of cyclic [3H]AMP. In contrast to these 
inhibitory effects, DzO enhanced markedly the 
glucose effect on intracellular cyclic AMP, this action 
augmenting with time (105% and 258% increment 
after 15 and 60 min incubation, respectively). 
In table 1, the effects of DzO on glucose are 
compared with those of two other stimulators of 
islet cyclic AMP, a high concentration of IBMX 
(1 .O mM) and cholera toxin. The efflux of cyclic [3H. 
AMP induced by the former two agents, as well as 
insulin release, were depressed by DaO, while no 
significant changes were seen in the presence of 
cholera toxin. DzO had a pronounced enhancing 
effect on glucose-induced intracellular accumulation 
of cyclic AMP, while it augmented the effects of 
IBMX to a modest extent, and did not change signifi- 
cantly that of cholera toxin. Thus, in the presence of 
1.0 mM IBMX, Da0 increased the intracellular radio- 
active nucleotide by 60%, while the effect of cholera 
0.3- 
0.2 - 
toxin was augmented by 20% (not significant), and 
the action of 27.7 mM glucose was amplified 2-fold. 
The effect of DzO on the phosphodiesterase activity 
of islet homogenates is shown in fig.2. At all substrate 
concentrations tested (2.1-0.26 PM cyclic AMP) a 
small inhibition (mean 14%) was noted in the presence 
of 50% of DzO. 
4. Discussion 
It is a common finding to all tissues tested so far 
that stimulation of intracellular cyclic AMP levels is 
accompanied by release of the nucleotide to the 
extracellular space. The present report adds deuterated 
water to a number of agents shown in other biological 
systems to inhibit this release [ 1 l- 141. As documented 
for DaO, some of these agents also increase intra- 
cellular levels of nucleotide. In addition, without any 
obvious parallelism to other studies, we report that 
the intracellular augmentation of cyclic AMP by Da0 
1 
/ 
kAMP] (PM-‘) 
Fig.2. Effects of 50% D,O (closed circles) on the phosphodiesterase activity in islet homogenates. Control values are denoted by 
open circles. Results are presented as a double reciprocal plot where the mean + S.E.M. (of 3 complete experiments) are indicated 
together with the lines of best fit, obtained by the method of least squares. 
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depends on the initial stimulus of a cyclic nucleotide 
response in the islets, the glucose response being 
amplified to a much higher degree than that of IBMX. 
Our findings with cholera toxin should be inter- 
preted with caution. Deuterated water neither 
influenced the effect of cholera toxin on release nor 
on intra-islet cyclic AMP. This lack of effect, which 
is in contradistinction to the findings in the presence 
of 1 .O mM IBMX and a low glucose concentration, 
may reflect different actions of DzO when adenylate 
cyclase activity is basal (IBMX) or stimulated (cholera 
toxin). However, it should be emphasized that the 
islets were incubated with cholera toxin for only 
30 min, which did not allow the full toxin effect to 
express itself. Thus, the lag period of toxin activation, 
together with the time-dependency of the D20 effect 
(fig.1) may have rendered our incubation conditions 
unfavourable for detecting possible effects of DzO. 
The question arises whether intracellular cyclic 
AMP elevation in response to DzO and other agents 
occurs secondarily to inhibition of extruded nucleo- 
tide. Although such a possibility cannot be excluded 
it is not supported by available data indicating that 
the turnover of cyclic AMP is probably very high in 
all tissues tested and also in the islet [7]. This would 
suggest hat only a minute fraction of the produced 
nucleotide per time unit is secreted, the inhibition of 
which would not appreciably change the intracellular 
content of cyclic AMP. 
The present results render unlikely one obvious 
possibility of DzO action on islet cyclic AMP meta- 
bolism, namely inhibition of the phosphodiesterase 
enzymes, the activity of which was inhibited by only 
about 15% in islet homogenates. Apart from these 
findings, a tentative explanation of the D?O effects 
relies on circumstantial evidence as follows: 
(1) Although it is conceivable that DzO interferes 
with multiple enzymatic processes, the stabilizing 
effect on microtubules is the most striking and well 
established one (2,lS). (2) Cyclic AMP may interact 
with microtubules to regulate the turn-over between 
polymerized and soluble subunits [ 161. (3) In islets, 
obtained under similar conditions as in the present 
experiments, glucose increases polymerized micro- 
tubular subunits [ 171. As a working hypothesis we 
thus suggest hat the glucose action on microtubules 
involves its effect on cyclic AMP, the binding of 
which may be increased as a result of the decreased 
turnover between polymerized and soluble micro- 
tubular units brought about by DzO. 
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